EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC 4.0

Quality indicators for selected types of cancers: a scoping review

Matías Libuy, Xaviera Molina, Óscar Arteaga, Paula Bedregal, Cristian Rebolledo, Marion Luan, Carolina de la Fuente, Victoria Lermanda, Pedro Zitko

IJQHC Communications · 04.07.2026 · 6 (2)

DOI: 10.1093/ijcoms/lyag043 ↗

Kurz gefasst

Scoping Review in der Zeitschrift IJQHC Communications, online erschienen am 01.10.2026. Verfasst von Matías Libuy und 8 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research and Development Agency.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer is a leading cause of death in Chile, exposing persistent inequities and gaps in the quality and timeliness of care. Up-to-date, comparable quality indicators are essential to evaluate performance across the cancer care continuum. This scoping review identifies and classifies oncology quality indicators for high-prevalence cancers in Chile using Donabedian’s framework (structure, process, outcome) and Chiew’s care components (prevention, screening, diagnosis, staging, pre-treatment evaluation, treatment, follow-up).

Methods

Following the PRISMA-ScR guideline, we systematically searched 13 international databases and grey-literature sources between July 2023 and July 2024. Eligible records were studies or policy documents describing, validating, or applying oncology quality indicators for breast, cervical, prostate, gastric, colorectal, gallbladder, or lung cancer in English or Spanish (1990–2024). Two reviewers independently screened, extracted, deduplicated, and harmonized indicators using a pre-specified definition of indicator uniqueness. The protocol was registered in the Open Science Framework (DOI: 10.17605/OSF.IO/BQXYN).

Results

From 4200 records, 59 publications were included, yielding 707 unique indicators: 38 structure, 593 process, and 76 outcome. Most addressed treatment, while few covered prevention, screening, or follow-up. No quality indicators for gallbladder cancer were identified within the English- and Spanish-language literature searched—a major evidence gap for a tumour of high national burden. Heterogeneity of indicator definitions and lack of equity-sensitive measures limited cross-cancer comparability.

Conclusion

Quality measurement in oncology remains unbalanced: indicators are abundant for lung, breast, and colorectal cancers but scarce for gastric and cervical cancer, and none were retrieved for gallbladder cancer within the English- and Spanish-language literature searched. Standardized, equity-oriented indicators for underrepresented cancers are critical for monitoring and policy in Chile and similar middle-income settings. To strengthen the link between measurement and patient-level results, we recommend that core indicator sets explicitly pair each process indicator with at least one measurable downstream outcome.

Förderung

  • National Research and Development Agency

Zitieren

APA

Libuy, M., Molina, X., Arteaga, Ó., Bedregal, P., Rebolledo, C., Luan, M., Fuente, C. D. L., Lermanda, V., & Zitko, P. (2026). Quality indicators for selected types of cancers: a scoping review. IJQHC Communications, 6(2). https://doi.org/10.1093/ijcoms/lyag043

Vancouver

Libuy M, Molina X, Arteaga Ó, Bedregal P, Rebolledo C, Luan M, et al. Quality indicators for selected types of cancers: a scoping review. IJQHC Communications. 2026;6(2). doi:10.1093/ijcoms/lyag043

BibTeX
@article{Libuy2026,
  author = {Libuy, Matías and Molina, Xaviera and Arteaga, Óscar and Bedregal, Paula and Rebolledo, Cristian and Luan, Marion and Fuente, Carolina de la and Lermanda, Victoria and Zitko, Pedro},
  title = {Quality indicators for selected types of cancers: a scoping review},
  journal = {IJQHC Communications},
  year = {2026},
  volume = {6},
  number = {2},
  doi = {10.1093/ijcoms/lyag043}
}
Kostenlos starten →